Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Ovarian Adnexal Mass Assessment Score Test System

March 23, 2011 8:30 am | by U.S. Food & Drug Administration | News | Comments

This document was developed as a special controls guidance to support the classification of ovarian adnexal mass assessment score test system into class II (special controls). An ovarian adnexal mass assessment score test system measures one or more...

Polar Partners with 'Shedding for the Wedding' Trainer and NGRâ„¢ President and CEO Jennifer Cohen

March 23, 2011 7:31 am | by Bio-Medicine.Org | News | Comments

LAKE SUCCESS, N.Y., March 23, 2011 /- Polar ( www.polarusa.com ), the leader in heart rate monitoring and fitness assessment technology, today announced a partnership with celebrity fitness trainer and health authority Jennifer Cohen .  Polar selected Cohen, president and CEO of...

Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genousâ„¢ Stent in Diabetic Patients

March 23, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, March 23, 2011 /- OrbusNeich today announced that 12-month outcomes data from a subset analysis of the global e-HEALING registry were published online ahead of print in the Journal of Interventional Cardiology and demonstrated the effectiveness and safety of the company's...

Advertisement

Poll: Do You Use Twitter?

March 23, 2011 5:33 am | by Diagnostic Imaging | News | Comments

Twitter's popularity continues to grow, and hundreds of physicians are turning to the 140-character platform to connect and share information. Do you tweet?

Are Your Managed Care Agreements Performing?

March 23, 2011 5:32 am | by Diagnostic Imaging | News | Comments

As providers continue to wrestle with both the planned and unknown annual reductions in reimbursement, it is critically important to understand the managed care component of your payer mix - and more importantly, to understand if each contract is delivering its intended benefit(s).

PRA International Experts to Speak at Industry Events

March 23, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., March 23, 2011 /- PRA International, a leading Clinical Research Organization, announces that two of our experts will be speakers at the upcoming Partnerships in Clinical Trials and Late Phase Drug Development conferences. PRA will also be exhibiting at both conferences....

Huifeng Bio-Pharmaceutical Technology Announces New Senior Vice President of Finance

March 23, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

XI'AN, China, March 23, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB ) ("Huifeng" or "the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives,...

DATATRAK to Attend DIA's 23rd Annual EuroMeeting

March 23, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, March 23, 2011 /- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its participation in the Drug Information Association's EuroMeeting. The 23rd Annual...

Advertisement

NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002

March 23, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich., March 23, 2011 /- NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.  Previously, NephRx reported that NX002 had demonstrated significant...

New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers

March 23, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., March 23, 2011 /- According to findings from the new nationwide DISCUSS ( D efining and I dentifying Gap S in C omm U nication between GERD and/or Heartburn S ufferers and Physician S ) Survey, many people surveyed report that their gastroesophageal reflux disease (GERD)...

Xenon Chief Scientific Officer, Dr. Michael Hayden Receives Prestigious Award for Leadership in Medicine

March 23, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, March 23, 2011 /- Dr. Michael Hayden, a Xenon founder and Chief Scientific Officer, has received the Canada Gairdner Wightman Award for leadership in medical science in Canada. The Wightman Award is another major honour for Dr. Hayden, having previously been...

Winner Medical Wins the Circular Economy Project Award

March 23, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, March 23, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, proudly announced today that...

Boston Scientific to Webcast Analyst Event

March 22, 2011 1:34 pm | by Boston Scientific | News | Comments

NATICK, Mass., March 22, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it will hold an analyst event on April 4, 2011 at the 60th Annual Scientific Session of the American College of Card

Advertisement

ReGen to FDA: 'Thanks, But No Thanks'

March 22, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, March 22, 2011 /- ReGen Biologics, Inc. (ReGen), manufacturer of the popular and successful Menaflex Collagen Meniscus implant, today declined the U.S. Food and Drug Administration's (FDA) offer of a hearing under 21 CFR Part 16 before the agency formalizes its decision to...

BlueLibris to Launch New Mobile Monitoring Devices on AT & T Network

March 22, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

DALLAS, March 22, 2011 /- AT&T * today announced an agreement with BlueLibris to provide wireless connectivity for a personal monitoring device. The BlueLibris small wearable device allows real-time communication with an adult or child wearing the device through call-center...

Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat

March 22, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

DETROIT, March 22, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) is the first healthcare provider in Michigan to offer a new breakthrough technology designed to correct atrial fibrillation (irregular heartbeat) in patients who struggle...

Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System

March 22, 2011 10:37 am | by Bio-Medicine.Org | News | Comments

MOUNT PROSPECT, Ill., March 22, 2011 /PRNewswire-USNewswire/ -- The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that the prescription monitoring programs (PMPs) of North Dakota , Ohio , and Virginia have entered into agreements to participate in...

SimQuest Develops World's First Platform for Open Surgical Simulation

March 22, 2011 10:37 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., March 22, 2011 /- SimQuest LLC, a leading developer of technology-assisted education and training, has developed the first platform for open-incision surgical simulation, which will enable surgeons to practice open surgical techniques with no risk to patients. The...

Student's love for family apparent in his 2 for OneShot system

March 22, 2011 10:35 am | by Arizona State University | News | Comments

From homelessness to greatness, ASU student Tyler Eltringham has seen the ups and downs of life. read more

Terso Solutions Launches New RFID-Enabled Refrigerator for Hospital and Laboratory Inventory Management

March 22, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., March 22, 2011 /- Terso Solutions, Inc. has expanded its line of RFID-enabled enclosures with the addition of a new refrigerator that is well-suited for hospital and laboratory inventory management . Leveraging the power of RFID, the new refrigerator makes better use of...

EMDT, MD+DI, and Qmed Announce Virtual Event Dedicated to Developments in Materials for Medical Applications

March 22, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, March 22, 2011 /- UBM Canon's Medical Device Media Group today announced its leading brands, EMDT ( European Medical Device Technology ), MD+DI ( Medical Device & Diagnostic Industry ), and Qmed, the world's only 100% qualified medical device supplier directory and search...

Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives

March 22, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., March 22, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug...

Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board

March 22, 2011 6:38 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, March 22, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today announced the appointment of  J. Michael Pearson, currently Valeant's Chief Executive Officer (CEO), as Chairman of the Board of Directors, replacing Robert A. Ingram,...

Dental Bib Chains are Potential Source for Infection and Disease

March 22, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C., March 22, 2011 /- Wet, used towels left in the gym. Dirty tissues discarded by someone suffering from a nasty cold. A toothbrush discovered in a hotel room. Most of us would never use or even touch these items. But without knowing it, we may be sharing something that...

Cinryze® (C1 Esterase Inhibitor Human) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting

March 22, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., March 22, 2011 /- ViroPharma Incorporated (Nasdaq: VPHM ) today announced data presented in two poster presentations relating to Cinryze® (C1 esterase inhibitor [human]) at the 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting, March 18...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading